MX9306814A - Nuevas 5-(amino n-heterosubstituidos) quinolonas antimicrobianas. - Google Patents

Nuevas 5-(amino n-heterosubstituidos) quinolonas antimicrobianas.

Info

Publication number
MX9306814A
MX9306814A MX9306814A MX9306814A MX9306814A MX 9306814 A MX9306814 A MX 9306814A MX 9306814 A MX9306814 A MX 9306814A MX 9306814 A MX9306814 A MX 9306814A MX 9306814 A MX9306814 A MX 9306814A
Authority
MX
Mexico
Prior art keywords
quinolonas
heterosubstituted
antimicrobial
amino
new
Prior art date
Application number
MX9306814A
Other languages
English (en)
Inventor
Thomas Prosser Demuth Jr
Ronald Eugene White
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX9306814A publication Critical patent/MX9306814A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Esta invención se relaciona con nuevos compuestos antimicrobianos, composiciones y métodos de tratamiento. En particular, los compuestos de esta invención consisten de una quinolona o una porción heterocíclica relacionada.
MX9306814A 1992-10-30 1993-10-29 Nuevas 5-(amino n-heterosubstituidos) quinolonas antimicrobianas. MX9306814A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96896092A 1992-10-30 1992-10-30

Publications (1)

Publication Number Publication Date
MX9306814A true MX9306814A (es) 1994-07-29

Family

ID=25514997

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306814A MX9306814A (es) 1992-10-30 1993-10-29 Nuevas 5-(amino n-heterosubstituidos) quinolonas antimicrobianas.

Country Status (21)

Country Link
EP (1) EP0666853A1 (es)
JP (1) JPH08502750A (es)
KR (1) KR950704301A (es)
CN (1) CN1064357C (es)
AU (1) AU687018B2 (es)
BR (1) BR9307347A (es)
CA (1) CA2148003A1 (es)
CZ (1) CZ282581B6 (es)
EG (1) EG20543A (es)
FI (1) FI952049A0 (es)
HU (1) HUT72072A (es)
IL (1) IL107323A (es)
MX (1) MX9306814A (es)
NO (1) NO951640L (es)
NZ (1) NZ257470A (es)
PL (1) PL178094B1 (es)
RU (1) RU2126000C1 (es)
SG (1) SG59979A1 (es)
SK (1) SK54795A3 (es)
WO (1) WO1994010163A1 (es)
ZA (1) ZA938089B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
WO1996004286A1 (en) * 1994-08-02 1996-02-15 The Procter & Gamble Company Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
ATE190972T1 (de) * 1994-08-02 2000-04-15 Procter & Gamble Verfahren zur herstellung von antimikrobiellen verbindungen
DK0882725T3 (da) * 1996-02-09 2003-01-13 Toyama Chemical Co Ltd Quinoloncarboxylsyrederivater eller deres salte
EP2594272B1 (en) * 2005-05-18 2018-07-11 Horizon Orphan LLC Aerosolized fluoroquinolones and uses thereof
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
CA2528849C (en) 2005-06-08 2014-01-14 Janssen Pharmaceutica N.V. Quinoline derivatives as antibacterial agents
EA010601B1 (ru) * 2005-06-09 2008-10-30 Янссен Фармацевтика Н.В. Производные хинолина в качестве антибактериальных агентов
CN101020647B (zh) * 2007-02-14 2011-03-30 杭州师范学院 一种β-环丙胺基丙烯酸(酯)的合成方法
JP5363350B2 (ja) * 2007-03-19 2013-12-11 武田薬品工業株式会社 Ｍａｐｋ／ｅｒｋキナーゼ阻害剤
CA2701630C (en) * 2007-10-05 2016-10-25 Cylene Pharmaceuticals, Inc. Quinolone analogs and methods related thereto
US8349829B2 (en) * 2008-06-03 2013-01-08 Actelion Pharmaceuticals Ltd. [4-(1-amino-ethyl)-cyclohexyl]-methyl-amine and [6-(1-amino-ethyl)-tetrahydro-pyran-3-yl]-methyl-amine derivatives as antibacterials
HUE050147T2 (hu) 2008-10-07 2020-11-30 Horizon Orphan Llc Tüdõgyulladás csökkentése levofloxacin belélegzése útján
NO2344129T3 (es) 2008-10-07 2018-07-21
AR076222A1 (es) * 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
RU2563809C2 (ru) 2009-09-04 2015-09-20 Мпекс Фармасьютикалс, Инк. Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
PL166381B1 (pl) * 1989-08-16 1995-05-31 Pfizer Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL
ES2147721T3 (es) * 1990-04-18 2000-10-01 Procter & Gamble Pharma Quinolonil lactamas antimicrobianas.
CA2095338C (en) * 1990-11-30 2002-04-09 John Michael Domagala Individual stereoisomers of 7-¬3-(aminoalkyl)-1-pyrrolidinyl|-quinolonesand naphthyridones as antibacterial agents

Also Published As

Publication number Publication date
HU9501237D0 (en) 1995-06-28
CN1064357C (zh) 2001-04-11
ZA938089B (en) 1994-06-07
CZ109795A3 (en) 1995-12-13
RU2126000C1 (ru) 1999-02-10
IL107323A (en) 2000-06-01
JPH08502750A (ja) 1996-03-26
SK54795A3 (en) 1995-12-06
NO951640D0 (no) 1995-04-28
BR9307347A (pt) 1999-05-25
CA2148003A1 (en) 1994-05-11
NO951640L (no) 1995-06-30
RU95110762A (ru) 1997-01-10
FI952049A (fi) 1995-04-28
EP0666853A1 (en) 1995-08-16
NZ257470A (en) 1997-08-22
IL107323A0 (en) 1994-01-25
CZ282581B6 (cs) 1997-08-13
PL308671A1 (en) 1995-08-21
CN1092773A (zh) 1994-09-28
WO1994010163A1 (en) 1994-05-11
HUT72072A (en) 1996-03-28
AU5409794A (en) 1994-05-24
KR950704301A (ko) 1995-11-17
SG59979A1 (en) 1999-02-22
AU687018B2 (en) 1998-02-19
FI952049A0 (fi) 1995-04-28
EG20543A (en) 1999-07-31
PL178094B1 (pl) 2000-02-29

Similar Documents

Publication Publication Date Title
MX9306814A (es) Nuevas 5-(amino n-heterosubstituidos) quinolonas antimicrobianas.
NO943002D0 (no) Fosfono-oksymetyletere av taxanderivater
FI923252A (fi) Antimikrobiella kompositioner.
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
FR2692755B1 (fr) Composition antimicrobienne.
DK0467792T3 (da) Fungicid komposition til behandling af udsæd
DK0920421T3 (da) Isoxazolinderivater anvendelige som antimikrobielle midler
IT8919316A0 (it) Benzoderivati di composti eterociclici contenenti azoto.
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
ES2059294T1 (es) Inhibidores de proteasas retroviricas.
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
TR199901765T2 (xx) S�lfomid-metalloproteaz inhibit�rleri
NO953371L (no) Anvendelse av anti-konvulsiva ved behandling av neuro-AIDS
NO20001483L (no) Nye NPY-agonister
BR9711586A (pt) Compostos e uso dos mesmo
ES2195397T3 (es) Quinazolin-2,4-dionas sustituidas en posicion 7 utiles como agentes antibacterianos.
DK0604183T3 (da) HIV-protease-inhibitorer anvendelige i behandlingen af AIDS
DE69426333D1 (de) Verbesserungen von antibakterischen zusammensetzungen
DE69104448D1 (de) Faserbehandlungsmittelzusammensetzung.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
DK1147105T3 (da) Optisk aktivt pyridyl-4H-1,2,4-oxadiazinderivat og anvendelse af dette til behandling af karsygdomme
NO911459D0 (no) Anvendelse av metallion-komplekser som belegginhibitorer.
MX9304626A (es) Derivados heterociclicos utiles en el tratamiento de enfermedades cardiovasculares.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees